BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.06.12 | Zurich Insurance buy | Vontobel Research | |
| 01.06.12 | Swiss Re buy | UBS AG | |
| 01.06.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 01.06.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 01.06.12 | Lonza hold | Vontobel Research | |
| 31.05.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 31.05.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 31.05.12 | Swiss Re buy | Sarasin Research | |
| 31.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
| 31.05.12 | Holcim overweight | Morgan Stanley | |
| 31.05.12 | Holcim equal-weight | Morgan Stanley | |
| 31.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 31.05.12 | Swiss Re buy | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Roche buy | Deutsche Bank AG | |
| 30.05.12 | Novartis outperform | Credit Suisse Group | |
| 30.05.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | UBS neutral | Sarasin Research | |
| 29.05.12 | Richemont kaufen | Euro am Sonntag | |
| 29.05.12 | Swisscom hold | Vontobel Research | |
| 25.05.12 | Zurich Insurance buy | ING | |
| 23.05.12 | Sonova buy | Vontobel Research | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 22.05.12 | Zurich Insurance halten | Independent Research GmbH | |
| 22.05.12 | Sonova neutral | Sarasin Research | |
| 22.05.12 | Sonova buy | Vontobel Research | |
| 22.05.12 | Lindt neutral | Sarasin Research | |
| 21.05.12 | Straumann hold | Vontobel Research | |
| 18.05.12 | Sonova equal-weight | Morgan Stanley | |
| 18.05.12 | Novartis hold | Vontobel Research | |
| 18.05.12 | Richemont buy | Vontobel Research | |
| 17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.12 | Richemont neutral | Sarasin Research | |
| 16.05.12 | Julius Bär equal-weight | Morgan Stanley | |
| 16.05.12 | Straumann hold | Vontobel Research | |
| 16.05.12 | Richemont buy | Vontobel Research | |
| 16.05.12 | Julius Bär hold | Vontobel Research |